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Background: Clinical data gathered for administrative purposes often lack sufficient information to separate the
records of radiotherapy given for palliation from those given for cure. An absence, incompleteness, or inaccuracy of
such information could hinder or bias the study of the utilization and outcome of radiotherapy. This study has
three specific purposes: 1) develop a method to determine the therapeutic role of radiotherapy (TRR); 2) assess the
accuracy of the method; 3) report the quality of the information on treatment “intent” recorded in the clinical data
in Ontario, Canada. A general purpose is to use this study as a prototype to demonstrate and test a method to
assess the quality of administrative data.
Methods: This is a population based retrospective study. A random sample was drawn from the treatment records
with “intent” assigned in treating hospitals. A decision tree is grown using treatment parameters as predictors and
“intent” as outcome variable to classify the treatments into curative or palliative. The tree classifier was applied to
the entire dataset, and the classification results were compared with those identified by “intent”. A manual audit
was conducted to assess the accuracy of the classification.
Results: The following parameters predicted the TRR, from the strongest to the weakest: radiation dose per
fraction, treated body-region, disease site, and time of treatment. When applied to the records of treatments given
between 1990 and 2008 in Ontario, Canada, the classification rules correctly classified 96.1% of the records. The
quality of the “intent” variable was as follows: 77.5% correctly classified, 3.7% misclassified, and 18.8% did not have
an “intent” assigned.
Conclusions: The classification rules derived in this study can be used to determine the TRR when such
information is unavailable, incomplete, or inaccurate in administrative data. The study demonstrates that data
mining approach can be used to effectively assess and improve the quality of large administrative datasets.
Keywords: Role of radiotherapy, Treatment intent, Palliation, Administrative data, Missing data, Data quality,
Classification, Decision treeBackground
Radiotherapy is an important type of treatment for cancer.
The role of radiotherapy in the management of cancer
could be either for curing the disease or for palliation when
the disease is deemed incurable. Along with the differences
in the anticipated clinical outcomes, radiotherapy is pre-
scribed differently in curative and palliative settings [1].
Many clinical studies concerning radiotherapy require the
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article, unless otherwise stated.There has been an increased interest in studying the
utilization of palliative radiotherapy at the population level
[2-7]. These studies require the researchers to correctly
separate the treatments given for palliation from those
given for cure. If the information on the TRR is incomplete
in the data, the utilization rates could be seriously underes-
timated. On the other hand, if the goal of the study is to
investigate the outcome of the curative radiotherapy, an
incorrect classification of the TRR (for example, many pal-
liative treatments were misclassified as curative treatments)
could lead the researcher to observe an outcome poorer
than the actual outcome.see BioMed Central. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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consistent and reliable way to determine the TRR. Most
population-based studies rely on administrative data, in
which treatment “intent” is recorded by radiation oncolo-
gists and entered into their computer system by a radio-
therapist or clinical clerk. However, such information is
not always available [2] and transcription errors could
occur. Moreover, treatment “intent” could change during
the course of treatment, depending on the response to
treatment and the progression of the disease. For these rea-
sons, researchers often apply certain rules to enhance the
information on “intent”. These rules were primarily based
on the number of fractions given in a course of treatment
combined with other information such as body-region and
time-to-death to distinguish palliative from curative treat-
ments [4,8].
There are challenges in adopting these rules to deter-
mine the TRR. For example, in order to establish a cutoff
for the number of fractions given in a palliative course
of treatment versus a curative course, we first need to
group the consecutive treatments into courses. Many
clinical systems used to capture treatment information
do not combine the records of treatment into courses.
In the cases where the treatments are combined into
courses, the definition of course varies. A shorter sur-
vival time after treatment often indicates that a patient
has received palliative therapy. However, vital statistics
are not readily available in clinical databases. In addition,
the establishment of these rules are arbitrary in nature,
and the validity of these rules has not been assessed.
We developed a data driven approach that utilizes the
treatment parameters captured in the Record and Verify
System (R&V system) during the treatment planning and
delivery to determine the TRR. Using a decision tree
method, we derived a set of classification rules and applied
these rules to the clinical data in Ontario, Canada. We
also conducted a manual audit to evaluate the validity of
these rules. The method described here can be applied to
other data sets or variables to assess and improve the
quality of administrative data.
Method
1. Source of dataBefore April 2004, radiotherapy in Ontario was
provided by eight Regional Cancer Centres managed
by a provincial agency Cancer Care Ontario (CCO).
All clinical activities were managed through the
Oncology Patient Information System (OPIS). After
an episode of treatments were given, treatment
details on paper records were summarized and
entered into the OPIS by a radiotherapist. Variables
in the radiotherapy summary data include start andend date of treatment, total dose (in cGy), total
number of fractions, all irradiated body-regions,
treatment techniques, and treatment “intent”.
Since 2005, the radiotherapy clinics in Ontario
were integrated into their hosting hospitals. The
radiotherapy data were collected by each hospital
and submitted to CCO in a standard data format,
the CCO Databook format [9]. These data were
extracted from the R&V System by treating
hospitals. There are two common R&V Systems
in North American: Aria (Varian Medical Systems,
Palo Alto, CA) and Mosaiq (Elekta, Stockholm,
Sweden). Both systems record similar information
on treatment activities and have the ability to
archive the data to an external storage. Both
systems are used in Ontario. In the R&V System,
each daily activity of radiotherapy is recorded as a
separate record. The information transferred to
CCO includes registration date, treatment date,
irradiated body-region, fraction-size (dose per
fraction), treatment technique, and treatment
“intent”. These data can be readily linked to hospital’s
central patient system to obtain information on
disease site and stage at diagnosis.
For the purpose of this study, we have linked the
clinical data to the Ontario Cancer Registry to
isolate the records of treatment given to malignant
cancers. We also attached the date and cause of
death to the radiotherapy data for the purpose of
audit. The use of the data for this study is approved
by the Health Sciences Research Ethics Board of
Queen’s University (Study ID: ONGY-134-00,
Ethics Romeo file# 6005177).2. Rule inductionWe used the data on the treatments given between
April 2005 and November 2008, collected in the
CCO Databook format, to derive the classification
rules. The study data set contained 336,393
treatment records randomly selected from the
records with “intent” assigned in the treating
hospitals. Overall, 14% of the treatment records
were for palliation, affecting 34% of the patients.
The analysis was conducted using SAS Enterprise
Miner software (SAS Institute, Cary, North
Carolina, USA).
Disease sites (ICD codes) were grouped into site
groups according to anatomic region and the
likelihood of being treated with radiotherapy. Irradiated
body-regions were grouped into body-region groups
according to proximity and to reflect whether a body-
region was likely to be treated palliatively or curatively.
Treatment dates were expressed as the number of days
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for the same cancer. Radiotherapy techniques were
classified to identify single-field versus multi-field
treatments. The above variables were used as
classification variables. Treatment “intent” was
grouped into a binary (curative versus palliative)
outcome variable “intent-flag”.
We used decision tree analysis with Chi-square
Automatic Interaction Detection (CHAID) algo-
rithm [10] to grow the classification tree. The initial
“tree trunk” was all treatment records in the study
dataset. The data set was split into two groups
based on the value of each classification variables to
see if there is a statistically significant difference in
the value of classification variable between the two
groups. The most significant split was used to form
the first branching of the tree. The same process
was repeated for each of the new groups formed,
until a further split would lead to a group with less
than 400 records. The final branches of the tree
contained a series of groups that were maximally
different from one another on intent-flag. At each
step, a chi-square test with Bonferroni adjustment
was performed to determine whether a significant
split could be made. Only the splits that achieved a
p-value less than 0.2 were retained. English classifi-
cation rules were derived by following the path
from the root to each tree branch.3. Missing dataIn the study data set, all variables except treatment
date had missing values. The classification rules
derived using all variables would not apply when
one of the classification variables had a missing value.
We therefore grew 7 different trees using subsets of
classification variables. These 7 trees were ranked by
their misclassification rate; the model with lowest
misclassification rate received highest ranking. When
the full model could not be applied to a record due
to missing values in one or more classification
variables, models with less classification variables
were used. When more than one model could be
used in classification, the model with highest
ranking was used.4. ValidationInternal validationThe study data set was randomly divided into three
subsets for training (40%), validation (30%), and
testing (30%). The training set was used to grow the
tree; the validation set was used to calculate themisclassification rate; the test set was used to grow
a second tree to assess the reliability.Manual auditIn the internal validation described above, the
accuracy of each classification tree was calculated
by assuming that the intent-flag represents the true
TRR. In reality, this is not always the case due to
human errors in data entry and changes in treatment
protocols. A disagreement between intent-flag and
the TRR derived from the classification rules could
reflect errors in the data instead of an incorrect
classification. To assess the true error rates of
classification, we conducted a manual audit using
the treatment records of 1,000 randomly selected
patients. The random sample was stratified by
treatment centre, treatment period (before or
after April 2005), and whether or not the classi-
fied TRR agreed with the intent-flag. All treat-
ments ever received by these patients were pulled
from the database. The records were further
linked to other data sources to obtain the stage at
diagnosis and the vital status of patients to assist
the identification of the “true” TRR. The final
audit records were reviewed by an experienced
medical physicist to classify the treatment into
palliative or curative. The audit is blinded, in
which the medical physicist did not have access
to the intent-flag nor the derived TRR. The data
sets used in rule induction and validation are
illustrated in Figure 1.Results
1. Profile of study variablesTable 1 shows the profile of the variables used in
the final tree classifier. Treatment technique did
not contribute to the final model, and therefore
was not shown in the table. The result shows that
the average fraction-size for the treatments with a
curative “intent” was smaller than that for the
treatments with a palliative “intent”. The average
number of days elapsed between a given fraction
and the first fraction was more for curative than
for palliative treatments. The total number of
curative treatments versus palliative treatments
varied by treated body-region and disease site.
Column 4 shows that all variables except
treatment date had missing values in the data set.
Overall, 85% of the total treatment records had
complete information on all four classification
variables.


















Treatment records from 1990-2004
978,118 records
Figure 1 The treatment records used in the induction and validation of classification rules.
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classification variables is shown in Figure 2. The
training data set was first divided up into two
groups according to fraction-size. The records with
a fraction-size greater or equal to 277cGy were
further divided into two groups according to body-
region. The first group contains treatments given to
abdomen, chest, brain, bone, neck, and pelvis. The
majority of the records in this group had a palliative
“intent”. The treatments given to other body-regions
were further divided up into two groups according to
disease site. The majority of the records in the first
group had a curative “intent”, which include the
prostate/testis cancer patients received radiotherapy
to organs in pelvis region; head and neck cancer
patients received radiotherapy to head, skin cancer
patients received radiotherapy to skin. The other tree
branches could be interpreted in the same fashion.
The branches lead to a total of 10 end points, each
were classified either as curative or palliative accord-
ing to the “intent” of the majority records in that
subgroup.
The above tree structure was further described as a
set of English rules by following the path way that
leads to each of the end points. We also developed 7
different sub-trees using only 3, 2, or 1 classificationvariables. The sub-trees and the classification rules are
available from the authors upon request.3. Internal validationShown in Table 2 were the accuracy of the 7 different
classification trees, calculated by internal validation.
The table shows that, model 1 (the full model)
performed best on the validation data set. Among
the “misclassified” records, 2.2% were classified as
palliative while the intent-flag was curative, and 3.3%
were classified as curative while the intent-flag was
palliative. Model 2 (removing disease site) had a very
similar accuracy as model 1, while it “misclassified”
slightly more palliative records into curative. Model 3
(removing body-region) had a slightly lower accuracy
than model 1 and 2. Model 4 (removing both body-
region and disease site) had a very similar accuracy as
model 3. However, model 4 “misclassified” more
palliative treatments into curative than model 3 did.
Removing fraction-size from the full model (model 5,
6 and 7) resulted in a marked decrease in the perform-
ance of the models, suggesting that fraction-size was
the strongest predictor.
The tree structure remained the same after
repeating the analysis using the test dataset, except
for minor changes in the percentage of curative/
palliative cases at the endpoints. This second tree
Table 1 Classification variables used in decision tree analysis
Classification variables Description Completeness*
Curative Palliative
Fraction size (cGy) Median: 200 Median: 300 99%
Time from the first treatment (no. of days) Median: 19 Median: 9 100%
Body-region group 91%
Chest 123,378 (91%) 12144 (9%)
Organs and tissues in pelvis region 78,220 (97%) 2211 (3%)
Pelvis – single side 1,057 (44%) 1332 (56%)
Pelvis – both sides 27,902 (91%) 2685 (9%)
Brain 9,177 (52%) 8589 (48%)
Neck 16,378 (92%) 1336 (8%)
Head 14,256 (93%) 1020 (7%)
Bone – spine, limb, chest, head 3,817 (21%) 14353 (79%)
Abdomen 7,206 (73%) 2614 (27%)
Skin 983 (73%) 357 (27%)
Other regions 7,116 (96%) 262 (4%)
Disease site group 97%
Head/neck(140–144,146-149,160,161) 26,090 (97%) 924 (3%)
Other head/neck 3,735 (92%) 309 (8%)
Colon/intestines (152,153) 1,782 (58%) 1,271 (42%)
Rectum (154) 17,585 (91%) 1,709 (9%)
Liver (155) 140 (38%) 226 (62%)
Other GI (150,151,156-159) 6,736 (74%) 2,349 (26%)
Lung (162–165) 18,850 (55%) 1,5319 (45%)
Bone (170) 245 (68%) 114 (32%)
Soft tissue (171) 1,942 (86%) 303 (14%)
Melanoma (172) 1,390 (54%) 1,204 (46%)
skin (173) 134(85%) 23(15%)
Breast (174,175) 97,728 (93%) 6,897 (7%)
Ovary (183) 461 (46%) 541 (54%)
Other GYN (179–182,184) 1,2791 (90%) 1,391 (10%)
Prostate/Testis/Penis (185–187) 74,061 (95%) 3,896 (5%)
Bladder (188) 2,206 (67%) 1,075 (33%)
Kidney (189) 464 (24%) 1,504 (76%)
CNS (190–192) 7,524 (93%) 604 (7%)
Thyroid/Endo (193,194) 727 (70%) 318 (30%)
Unspecified group 1 (195,196) 1,271 (88%) 176 (12%)
Unspecified group 2 (197–199) 4,152 (66%) 2,153 (34%)
Lymphoid/leukemia(200,202,204-208) 7,295 (71%) 2,933 (29%)
Hodgkin’s disease (201) 1,697 (94%) 116 (6%)
Myeloma (203) 484 (24%) 1,548 (76%)
*The completeness was calculated using all records of treatment given between 2005 and 2008; while the summary statistics were based on the records used in
decision tree analysis, which are randomly selected from the records without missing data.
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Figure 2 The classification tree that predicts the therapeutic role of radiotherapy using treatment parameters.
Table 2 Model accuracy assessed by internal validation for 7 different models
Model Classification variables Number of rules Accuracy (CI) Confusion matrix
Model 1 Fraction-size 10 94.6% (94.4%, 94.7%) C to P*: 2.2%
Disease site P to C: 3.3%
Body-region
Time from the 1st treatment
Model 2 Fraction-size 13 94.5% (94.3%, 94.6%) C to P: 1.9%
Body-region P to C: 3.6%
Time from the 1st treatment
Model 3 Fraction-size 10 94.2% (94.0%, 94.3%) C to P: 2.4%
Disease site P to C: 3.4%
Time from the 1st treatment
Model 4 Fraction-size 8 94.1% (94.0%, 94.3%) C to P: 2.0%
Time from the 1st treatment P to C: 3.8%
Model 5 Disease site 18 92.0% (91.8%, 92.2%) C to P: 3.0%
Body-region P to C: 4.9%
Time from the 1st treatment
Model 6 Body-region 11 91.0% (90.8%, 91.2%) C to P: 2.4%
Time from the 1st treatment P to C: 6.6%
Model 7 Disease site 10 90.1% (89.9%, 90.3%) C to P: 3.8%
Time from the 1st treatment P to C: 6.2%
*’C’ refers to curative, ‘P’ refers to palliative.
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not shown.4. Manual auditTable 3 shows the performance of the classification
rules evaluated through an audit in which manual
classifications were used as “gold standard”. In this
analysis, sensitivity, specificity, positive and negative
predictive values were calculated using palliation as
the target outcome. Among the records for which the
classification rules and the intent-flag yielded the same
classification (sample A), the classifiers performed very
well, with sensitivity, specificity, positive and negative
predict values all above 95%. When the classification
rules and the intent-flag disagreed (sample B), the
classification rules did better in identifying curative
treatments (specificity 66.0%) while the intent-flag did
better in identifying palliative treatments (sensitivity
36.3%). Overall, the classification rules were more
effective in identifying curative treatments than identi-
fying palliative treatments. If a treatment were given
for palliation, it would be classified as palliative in
84.2% of the times. If a treatment were given for cure,
it would be classified as curative in 98.5% of the times.
The predictive power of the classification rules was
high for both curative and palliative treatments. If a
record were classified as palliative, the likelihood of be-
ing truly palliative was 92.3%; If a record were classi-
fied as curative, the likelihood of being truly curative
was 96.8%.
Utilizing the audit results, we estimated the
misclassification rates for the entire data set
(column 2 and 3 of Table 4). For the treatments
given between 2005 and 2008, 3.4% records did not
have an intent-flag, 4.2% was misclassified by the
classification rules and 4.1% was misclassified by
the intent-flag. The proportion of records correctly
classified was 95.8% by the classification rules and
92.5% by intent-flag. The classification rules performed
fairly well when applied to the treatments given
before 2005, which were collected in a different
format. For the entire study period between 19903 Validity of the classification rules based on a manual audit
ed patients
Sample A*
vity (palliative) 95.5 (94.2,96.8)
city (curative) 99.5 (99.4,99.7)
e predictive value (palliative) 97.3 (96.3,98.3)
ve predictive value (curative) 99.2 (99.0,99.4)
he records for which the classification rules and the intent-flag agreed.
the records for which the classification rules and the intent-flag disagreed.
sted for sampling stratification.and 2008, 96.1% of the records were correctly classi-
fied by the classification rules. Due to the poor avail-
ability of information on “intent” in the earlier period,
only 77.5% of the records were successfully classified
by intent-flag. Auditing only the records for which
the classification rules and the intent-flag disagreed
over-estimated the success rates by approximately 1%
(column 4 and 5).Discussion
This study demonstrates that the TRR could be ad-
equately predicted by treatment parameters such as
fraction-size, body-region, treatment time line, and dis-
ease site. This finding is important because the know-
ledge of TRR is needed for population-based clinical
studies, especially in the studies concerning palliative
radiotherapy. Since treatment “intent” is not an essen-
tial parameter for the delivery of radiotherapy, not all
clinics routinely collect information on “intent”. When the
information on “intent” is not available, the classification
rules described here could be used as a reasonable tool to
impute the data.
The decision tree presented here can also be used as a
tool to aid the quality assessment of administrative data.
Using administrative data to conduct clinical research has
become a well established methodology among health care
communities. However, the credibility of these studies de-
pends, to a great extent, on the quality of data [11]. Be-
cause the collection of administrative data is often not
monitored and controlled, human errors in data entry are
inevitable. The traditional approach of data quality assess-
ment requires retrospective review of medical records by
trained medical staff, which is labor intensive. Given the
massive volume of administrative data, such an audit is
often not viable. In this study, we isolated the records
whose intent-flag did not follow the prevailing trend dis-
played by the majority of records for audit purpose. This
targeted approach, although it slightly underestimated the
error rate, makes a routine audit of administrative data
much more feasible.
Other predictive models such as logistic regression could
also be used in this setting. We chose to use a decision tree
because it has a higher interpretability than a regressionof the treatment records of 1,000 randomly
Sample B** Entire sample***
36.3 (34.0,38.5) 84.2 (82.9,85.5)
66.0 (63.4,68.5) 98.5 (98.3,98.7)
58.6 (55.8,61.5) 92.3 (91.3,93.3)
43.8 (41.6,45.9) 96.8 (96.5,97.0)
Table 4 The performance of the classification rules and
the intent-flag for the records of treatments given
between 1990 and 2008 in Ontario
2005-2008


























% missing 0 3.4*** 0 3.4
1990-2008


























% missing 0 18.8 0 18.8
*Estimated through the audit of a random sample drawn from all
treatment records.
**Estimated through the audit of a random sample drawn from the records for
which the classification rules and the intent-flag disagreed.
***CI was not provided because the percentage of records missing intent was
observed instead of being estimated through the audit.
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opportunity for manual pruning of a specific branch. In the
classification tree shown in Figure 2, the various branches
can be explained by basic principles of radiation oncology.
For example, the predominance of fraction-size as a differ-
entiator between curative and palliative treatments comes
from the basic radiobiological principles of cell survival and
repair that guide radiation oncology. Since palliation is not
so concerned with the late effects of radiation, it does not
require the small fraction-sizes necessary for curative treat-
ments [13]. Despite this basic principle, there are some
disease sites such as prostate where hypo-fractionated
regimens are being promoted [14]. This can be seen on
the right hand side of Figure 2, where more accurate
classification was obtained when the fraction-size informa-
tion was combined with disease information. For the dis-
ease sites such as prostate and skin, treatments with a high
fraction-size were still considered curative, although this
accounted for less than 1% of the treatment fractions given.
For the treatment records with smaller fraction size (left
hand side of Figure 2), the next determinant factor was the
time interval between a given treatment and the time when
a patient received his/her first treatment. From Figure 2, it
appeared that the treatments given more than two-and-a-
half months after a patient started his/her first treatmentwere more likely to be palliative compared with the treat-
ments given within the first two-and-a-half months. This
reflects the fact that re-treatments are most likely to be
palliative. One may question why the median value of time-
from-the-first-treatment for curative treatments (19) was
larger than the same median value for palliative treatments
(9, Table 1). These median values reflect the fact that curative
treatments have a longer course than palliative treatments.
In evaluating the classification rules, we have calculated
the sensitivity and specificity of the classification. However,
one needs to keep in mind that classifying the TRR of treat-
ments is different from identifying a case of disease. Both
curative and palliative cases were treated with radiation,
except with different total dose and fraction size. On occa-
sions, the boundary of the classification is not very clear.
One example would be when a prescribed curative course of
treatments was terminated early due to various reasons. One
could argue that these treatments remain as curative because
they were prescribed for cure. We have encountered such
cases during the manual audit, when a typical course of cura-
tive treatments was terminated and switched to palliation to
other body regions with a different fraction size, or a patient
died of a heart failure during a course of curative treatments.
We have classified these treatments as “attempted cure” in
the audit. Because our model uses dose per fraction instead
of total dose for a course, these treatments would be classi-
fied as curative by the classification rules.
This study has several limitations. First, the information
included in decision tree is limited primarily to treatment
parameters. The stage of disease, co-morbidity, patient’s
performance status, the prior and concurrent treatment
and supportive care which a patient received, and a short
survival time are all potential predictors of TRR. Unfortu-
nately, such information is not available through the R & V
system; obtaining such information requires linking radio-
therapy data to other data sources. Although the linked
data could potentially improve the accuracy of the classifi-
cation, it increases the difficulty of the application of the
classification rules, particularly in the jurisdictions where
linkage of clinical data to other data sources is not a routine
practice. The performance status of cancer patients are not
routinely collected at the cancer clinics in Ontario. A rou-
tine collection of such data would strengthen population-
based clinical research.
Second, the performance of the classification rules de-
pends on the quality of the classification variables. The
fraction-size and treatment time are automatically entered
into the R&V system at the time of treatment, and there-
fore are an accurate recording of how much treatment a
patient received and when. The irradiated body-regions
are also recorded at the time of treatment. However,
body-regions are often recorded as verbatim descriptions,
and the interpretation of such information is challenging
for computerized analysis. In Ontario, the body-region
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region codes; human errors (interpretation, transcrip-
tion, typographical) inevitably occur during the coding
process. Likewise, primary disease site recorded in hos-
pitals are subject to the same types of human errors.
Because the decision tree model describes the general
pattern in the data, these errors are not likely to affect
the model itself. However, if the classification variables
of an individual record is erroneous, the record could
be misclassified. This, perhaps, has in part contributed
to the fact that body-region and disease site did not
predict the therapeutic role as well as fraction-size did.
Third, the classification rules are built upon the existing
overall pattern of radiotherapy practice. The performance
of the tree classifier depends on the uniformity and
consistency of radiotherapy practice. If current practice
changes, the rules will need to be updated to reflect
these changes. For example, there is currently a trend
towards hypo-fractionated treatments such as stereo-
tactic beam radiotherapy for small cell lung tumors. If
these practices become standard care, the classification
tree may need to rely more heavily on body-region and
disease site information. In addition, diseases with a
very low incidence rate that do not follow the general
pattern of treatment may not be captured correctly.
Therefore, applying this classification rules to the treat-
ments given to rare disease might be problematic.
Finally, the applicability of the derived classification rules
in other jurisdictions remains to be tested. Because all radi-
ation treatment units use R&V systems to plan and deliver
treatments, the data used in this study should be available
to all radiotherapy clinics worldwide. On the other hand,
Although the biological basis guiding the prescription of
radiotherapy is the same, minor variations in practice
across geographic regions may exist. Our audit results
showed that the performance of the tree classifier varied
from hospital to hospital in Ontario (data not shown).
Although this could reflect the variation in data quality, it
could also in part reflect the minor differences in clinical
practice in different hospitals. For the best results, sepa-
rate classification trees should be derived using regional or
institutional data to verify the validity of the classification
rules.
Conclusions
The classification rules derived in this study can be used
to determine the TRR when such information is unavail-
able, incomplete, or inaccurate in administrative data. The
study demonstrates that data mining approach can be
used to effectively assess and improve the quality of large
administrative datasets.
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